Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
2/19/2024
Updated
2/20/24, 11:36 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership